US2021366572A1PendingUtilityA1

Methods, models, systems, and apparatus for identifying target sequences for cas enzymes for crispr-cas systems for target sequences and conveying results thereof

Assignee: BROAD INST INCPriority: Dec 12, 2012Filed: Feb 23, 2021Published: Nov 25, 2021
Est. expiryDec 12, 2032(~6.4 yrs left)· nominal 20-yr term from priority
G16B 20/00G16B 20/30C12N 15/1089C12N 15/113C12N 9/22C12N 15/1082C12N 2320/11C12N 2310/20
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are thermodynamic and multiplication methods concerning CRISPR-Cas systems, and apparatus therefor.

Claims

exact text as granted — not AI-modified
1 . A method of identifying one or more unique target sequences in a genome of a eukaryotic cell, whereby the target sequence is susceptible to being recognized by a CRISPR-Cas system, wherein the method comprises:
 a) determining average cutting frequency of a particular mismatch position for a particular Cas nuclease from a training data set as to that Cas nuclease, wherein the mismatch is between a CRISPR-Cas system guide and a target sequence, and   b) determining average cutting frequency of a particular mismatch type for the particular Cas nuclease from the training data set,   to thereby obtain a ranking and identify one or more unique target sequences based on the ranking.   
     
     
         2 . The method of  claim 1 , comprising
 c) multiplying the average cutting frequency of a particular mismatch position by the average cutting frequency of a particular mismatch type to obtain a first product,   d) repeating steps a) to c) to obtain second and optionally further products for any further particular mismatch position(s) and mismatch type(s) and multiplying those second and optionally further products by the first product, for an ultimate product, and omitting this step if there is no mismatch at any position or if there is only one particular mismatch at one particular position, and   e) multiplying the ultimate product by the result of dividing the minimum distance between consecutive mismatches by the distance, in bp, between the first and last base of the target sequence and omitting this step if there is no mismatch at any position or if there is only one particular mismatch at one particular position, to thereby obtain the ranking.   
     
     
         3 . The method of  claim 1 , comprising creating the training data set as to a particular Cas nuclease before performing step (a). 
     
     
         4 . The method of  claim 2 , wherein the distance, in bp, between the first and last base of the target sequence is 18. 
     
     
         5 . The method of  claim 1 , wherein the average cutting frequency p est  is determined from p est ∝e −βZ     est   , where β is a positive constant of proportionality and Z est  is the effective free-energy determined using  =  where G is the local free energy and a are position dependent weights determined using the training set. 
     
     
         6 . The method of  claim 1 , further comprising producing a composition comprising (a) the Cas nuclease or a nucleic acid encoding therefor and (b) a CRISPR-Cas system guide or a nucleic acid encoding therefor, wherein the CRISPR-Cas system guide is capable of hybridizing to the unique target sequence and directing the Cas nuclease to the unique target sequence in the genome of the eukaryotic cell. 
     
     
         7 . The method of  claim 6 , wherein the Cas nuclease is Cas9. 
     
     
         8 . The method of  claim 6 , wherein the CRISPR-Cas system guide is a chimeric guide RNA. 
     
     
         9 . The method of  claim 6 , wherein the target sequence is a target DNA sequence. 
     
     
         10 . The method of  claim 6 , further comprising delivering the composition into the eukaryotic cell, wherein a CRISPR complex formed by the Cas nuclease and CRISPR-Cas system guide cleaves the target sequence within the eukaryotic cell. 
     
     
         11 . The method of  claim 1 , wherein the Cas nuclease is Cas9. 
     
     
         12 . The method of  claim 1 , wherein the CRISPR-Cas system guide is a chimeric guide RNA. 
     
     
         13 . The method of  claim 1 , wherein the target sequence is a target DNA sequence. 
     
     
         14 . The method of  claim 1 , wherein the target sequence is adjacent to a protospacer adjacent motif (PAM) in the genome of the eukaryotic cell. 
     
     
         15 . The method of  claim 14 , wherein the PAM comprises NGG, NNAGAAW, or NNGRR.

Join the waitlist — get patent alerts

Track US2021366572A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.